Skip to main content

DiaMedica Therapeutics Inc.

DMAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401040

No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding DiaMedica Therapeutics Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of DMAC: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders2826−2
Shares3.67M2.53M−1.14M (−31.1%)
Value$7.42M$3.14M−$4.28M (−57.7%)

New holders (5)

Institutions that held DiaMedica Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to DMAC in Q3 2022
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP35,258$44.0K0.00%
HRT Financial LP10,441$12.0K0.00%
Jane Street Group, LLC10,003$12.0K0.00%
Simplex Trading, LLC2,005$2.00K0.00%
Legend Financial Advisors, Inc.1,000$1.24K0.00%

Sold out (7)

Institutions that held DiaMedica Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of DMAC in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Stonepine Capital Management, LLC1,176,344$2.38M
Cantor Fitzgerald, L. P.14,691$30.0K
Shay Capital LLC10,000$20.0K
Newbridge Financial Services Group, Inc.1,269$3.00K
Patriot Financial Group Insurance Agency, LLC1,300$2.00K
Bank of America Corp3$0
Toronto Dominion Bank24$0